COVID-19 Key EU Developments, Policy & Regulatory Update No. 57

Jones Day is a global law firm with more than 2,500 lawyers across five continents. The Firm is distinguished by a singular tradition of client service; the mutual commitment to, and the seamless collaboration of, a true partnership; formidable legal talent across multiple disciplines and jurisdictions; and shared professional values that focus on client needs.

Explore Firm Details

This regular alert covers key regulatory EU developments related to the COVID-19 situation. It does not purport to provide an exhaustive overview of developments and contains no analysis or opinion.

European Union Coronavirus (COVID-19)

Article Insights

Kaarli H. Eichhorn’s articles from Jones Day are most popular:

in European Union
in European Union
in European Union
in European Union
in European Union
with readers working within the Media & Information industries

Jones Day are most popular:

within Strategy topic(s)

This regular update (no. 57 | 26 July 2021) covers key regulatory EU developments related to the evolving COVID-19 situation (Antitrust & State Aid; Trade/Export Controls; Medicines, Medical Devices and Personal Protective Equipment; and Cybersecurity, Privacy & Data Protection).

Attachments COVID19 KEY EU DEVELOPMENTS No 57

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

COVID-19 Key EU Developments, Policy & Regulatory Update No. 57

Contributor

Coronavirus (COVID-19)

Contributor

Belgium